Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™ in Healthy Subjects and Patients With Varying Degrees of Renal Impairment

NCT03095391 is registered in ClinicalTrials.gov with FAST BioMedical as lead sponsor.

NCT NCT03095391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03095391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™ in Healthy Subjects and Patients With Varying Degrees of Renal Impairment
Lead sponsor
FAST BioMedical
Phase
Observational
Overall status
Completed
Start date
June 13, 2017
Completion date
September 20, 2017
Enrollment
32 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, kidney diseases, renal insufficiency, renal insufficiency, chronic, urologic diseases